Tag: XmAb20717

Xencor launches phase 1 trial of XmAb20717 in advanced solid tumors

pharmanewsdaily- July 15, 2018

Xencor has launched a phase 1 clinical trial of its bispecific antibody XmAb20717, which is being developed for the treatment of multiple advanced solid tumors. ... Read More